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KEYS TO DELVE INTO THE SOCIAL PERCEPTION OF SCIENCE
doMinique Brossard
The latest biotechnology applications allow for faster and cheaper gene editing than ever before. 
Many people are calling for a public debate on these issues, including the social, cultural and ethical 
implications of these applications. On the other hand, the information available to citizens is 
sometimes contradictory and communication that takes all these aspects into account is important 
and increasingly necessary. Therefore, understanding public attitudes towards biotechnology should 
be a priority for the work ahead.
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Market applications of biotechnology have become 
commonplace, and new ones are appearing at a fast 
pace. Recently, the new gene editing tool CRISPR/
Cas9 has made gene editing faster, easier and cheaper, 
and agricultural products using the technique (i.e., 
the non-browning Arctic® apples) are already in 
the hands of the consumers in the United States. 
Applications in the human 
context are also becoming 
reality, with the journal Nature 
announcing in August 2017 
that for the first time, a gene 
responsible for heart failure had 
been successfully edited in a 
human embryo using CRISPR/
Cas9 (Ma et al., 2017). At the 
same time, regulations related 
to these scientific breakthroughs 
are still in flux. With many calling for broad public 
debates on these questions and citizens being 
confronted with often conflicting information, 
communication about these techniques is more than 
ever important.
So, what is biotechnology? Broadly construed, it 
is «the manipulation (as through genetic engineering, 
or GE) of living organisms or their components to 
produce useful commercial products» (Merriam-
Webster, 2018). The use of biotechnology in food 
contexts has been a reality for a long time (with some 
claiming that brewing techniques in beer-making are 
a form of biotechnologies), and the first commercial 
GE crop (a GE tomato with delayed ripening) was 
approved for commercial sale in the United States 
in the mid-1990s. GE crops are now grown on more 
than 12 % of the world cropland, with close to 40% 
of this acreage being in the United States (National 
Academies of Sciences, Engineering, and Medicine, 
2016). As is often the case with 
technologies that have not only 
scientific, but also legal, social 
and ethical dimensions, GE 
crops (and related genetically 
engineered foods, frequently 
called «GMOs») have been 
surrounded with controversy. 
Indeed, many around the world 
have voiced concerns about the 
potential risks posed by genetic 
engineering, while many others have stressed their 
potential benefits (see Brossard, 2012, for a review).
■■ UNDERSTANDING	PUBLIC	ATTITUDES	TOWARD	
BIOTECHNOLOGIES
It is well established that most citizens around the 
world do not know much about biotechnologies and 
their potential applications in agriculture and human 
health, but this has not prevented controversies around 
their use to flourish (Brossard, Nesbitt, & Shanahan, 
2007; Brossard, 2012). And although there is scientific 
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consensus that consuming GE crops does not pose a 
risk to human health – based on experiences to date, 
which are mostly restricted to herbicide resistant and 
insect resistant varieties of corn, cotton, and soybean 
(National Academies of Sciences, Engineering, and 
Medicine, 2016) –, a large number of consumers 
worldwide are still worried these technologies are 
dangerous to human health, among other concerns. 
So, is this a communication problem?
It might be a communication problem, but it is 
certainly not a knowledge deficit problem. It is well 
established that ignorance (or misunderstanding) 
of established scientific facts is often not the main 
reason why people reject scientific innovations 
(see Akin & Scheufele, 2017, for a review). Instead, 
individuals rely on cues provided by their values, their 
perceptions of the risks and benefits involved, their 
level of trust in the different information providers, 
and by how they see these issues covered in the 
media, to name just a few of the mental shortcuts 
people use to form attitudes toward controversial 
science (Brossard & Nisbet, 2007; National 
Academies of Sciences, Engineering, and Medicine, 
2016, 2017). People process information related to 
biotechnologies based on their preexisting values and 
beliefs, a process known as «motivated reasoning» 
(Kunda, 1990; Yeo, Cacciatore, & Scheufele, 
2015). In practical terms, this means that the same 
message about a scientific development such as 
biotechnology and its applications can be interpreted 
very differently by two individuals. According to 
this line of research, we all process information 
(including scientific evidence) in biased ways, and we 
use our religious views (Ho, Brossard, & Scheufele, 
2008; Brossard, Scheufele, Kim, & Lewenstein, 
2009), our cultural values (Kahan, Braman, Slovic, 
Gastil, & Cohen, 2009), or our deference to science 
(Brossard & Nisbet, 2007) among other values, to 
make sense of information about new, controversial 
technologies such as genetic engineering. More 
importantly, by processes called «confirmation bias» 
(and «disconfirmation bias»), we tend to give more 
importance to the information that confirms our 
beliefs and discard the one that does not (Yeo, Xenos, 
Brossard, & Scheufele, 2015).
This has important consequences for 
communication about biotechnology. When 
individuals express concerns about the potential 
health effects of consuming GMOs, even when 
knowing most scientists agree there is no evidence 
of such effects, they might not do so because they 
distrust science, or because they are ignoring science 
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may be giving more weight to fringe scientific studies 
that have concluded these health effects do exist 
(such as the widely circulated, although retracted, 
«Séralini study») than to the vast number of studies 
that have concluded otherwise (for a discussion 
of the Séralini study, see National Academies of 
Sciences, Engineering, and Medicine, 2016). In this 
hypothetical case, individuals might be concerned 
by the potential health effects of GMOs because 
they do not trust the regulatory system that is 
supposed to keep their food safe or because they 
distrust the corporations that are producing GMOs 
and industrial agriculture in general, to cite a few 
potential scenarios. Alternatively, they may feel that 
GMOs are unnatural and are messing up with nature 
and therefore should be avoided. These individuals 
will find the science that supports their beliefs to 
make their case, even if this science does not meet 
the quality standards expected by the scientific 
community and is expressed in a retracted peer-
reviewed article.
Insights from risk communication research 
are also important to take into account: public 
perceptions of the risks related to biotechnologies 
have more to do with the outrage (or negative 
emotional response) the technology provokes, rather 
than the hazard the technology poses in probabilistic 
terms. The more dreaded the technology, the more 
outrage it produces, and this dread may be linked to 
factors hard to measure with a purely technical risk 
assessment approach. Indeed, individuals may be 
expressing concerns about health or environmental 
risks, while be more generally concerned about 
the social, cultural and ethical implications of 
the technology (National Academies of Sciences, 
Engineering, and Medicine, 2016; see Covello, 2010 
for an overview of risk communication principles). 
With online environments providing platforms 
for individuals to share their outrage about new 
technologies and potentially contributing to the 
social amplification of the risks perceived, an 
understanding of the communication processes at 
play in these environments is crucial.
■■ COMMUNICATION	ABOUT	BIOTECHNOLOGIES	
AND	ONLINE	MEDIA	ENVIRONMENTS
Although there are clear disparities between 
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terms of Internet access (more individuals in North 
America and Europe have access to the Internet, 
compared with other parts of the world), access 
and use are growing rapidly around the globe (Pew 
Research Center, 2016). In practical terms, this 
means that people can have access to virtually 
unlimited information about anything, anywhere. 
However, when people search for information online 
about issues such as biotechnologies, the results 
presented by the search algorithms will take into 
account their previous searches as well as their 
other online behaviors. Search results will therefore 
make it likely individuals will be exposed mostly to 
information that supports their views, phenomena 
that have been labeled «filter bubbles». Individuals 
are also likely to connect online with others who 
think like them, reinforcing in the process their own 
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information about topics of interest on a multitude 
of social networks and writing their own content 
(Brossard, 2013, 2014).
Information about biotechnologies encountered 
online is not found in isolation. Unlike traditional, 
print news content, online news is contextualized 
by other readers, who can like or dislike content, 
post comments, and re-share content, with this 
contextualization having important effects on public 
attitudes toward technologies and on perceptions of 
the news media. Notably, rude comments following 
a science news story about nanotechnologies were 
shown to have a «nasty effect» on the readers, with 
those exposed to the rude comments ending up being 
more polarized about the technologies that those 
exposed to civil comments (Anderson, Brossard, 
Scheufele, Xenos, & Ladwig, 2013). And although 
the growth in the use of social media for news 
content is leveling somewhat 
– people are more and more 
using messaging applications 
such as Whatsapp to access 
news content (Reuters Institute, 
2017) –, the importance of online 
cues provided by readers on 
stories about biotechnologies 
cannot be dismissed. Likewise, 
the complexities of a science 
in constant evolution should 
also be taken into account, as perfectly illustrated by 
CRISPR/Cas9 and its use in human gene editing.
■■ COMMUNICATION	IN	AN	ERA	OF	POST	NORMAL	
SCIENCE
CRISPR/Cas9, the technology making gene editing 
easier, more precise and cheaper mentioned at the 
start of this essay, is a perfect illustration of what 
has been called post normal science. When ‘facts 
are uncertain, values in dispute, stakes high and 
decisions urgent’ (Funtowicz & Ravetz, 1992), policy 
debates have to go beyond the scientific community 
for expert input and need to include many voices. 
The CRISPR/Cas9 technology could potentially help 
eradicate human genetic diseases such as sickle cell 
anemia, but could also be used to enhance the human 
body and create designer babies. If germline editing 
is performed, the changes could be transmitted to 
future generations. While the myriad of ethical, legal 
and social implications of such applications have 
been extensive discussed (see National Academies of 
Sciences, Engineering, and Medicine, 2017), scientific 
research continues to advance at fast pace, some may 
say at a pace faster than the capacity for societies to 
develop adequate regulatory frameworks for such 
research and its applications.
And lay individuals want to be active participants 
in policy discussions about gene editing in general 
and human gene editing in particular. A recent survey 
of American adults found that public concerns do 
not match experts’ views of human gene editing 
(Scheufele et al., 2017). While the latter are concerned 
about the heritability of germline editing (that would 
be performed for therapeutic or enhancement reasons), 
the majority of Americans find the use of human 
genome editing for therapeutic purposes acceptable 
when achieved through either somatic or germline 
edits. However, when gene editing is used for human 
enhancement purposes, public opposition increases. 
More importantly, most respondents are in agreement 
that the scientific community «should consult with 
the public before applying gene 
editing to humans» (Scheufele et 
al., 2017) which brings us back 
to the concept of post normal 
science mentioned above and to 
communication related issues.
In an editorial published on 
22 February 2017, the journal 
Nature perfectly illustrated 
the current complexities of the 
legal landscape for gene editing 
technologies used in plants. The editors stressed 
the politicized nature of the debate in Europe as far 
as potential regulations were concerned as well as 
the unclear legal status of plant products produced 
with the CRISPR/Cas9 technology. Additionally, the 
editors called for plant scientists to engage with the 
public to discuss the issue and claimed that «reason 
and science need[ed] to prevail this time» and the 
safety and value of gene editing should therefore be 
widely communicated (Nature, 2017). Unfortunately, 
most scientists are not trained at communication and 
real, meaningful engagement is difficult and costly. 
Public engagement exercises that do not take into 
account public concerns and are not bi-directional 
are unlikely to be productive and may even backlash. 
At the end of the day, very often questions raised in 
public settings cannot be answered by science alone 
because they go beyond the technical aspects of the 
issue, as we discussed earlier on.
The release of a recent consensus report on 
genetically engineered crops by the National 
Academies of Sciences in the United States 
provides an example of sound communication about 
biotechnology. The report summarized the consensus 
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of a committee of international experts from 
a wide range of disciplines regarding the 
potential agronomical, environmental, health 
and socio-economic impacts of genetically 
engineered crops. It also discussed the 
regulatory issues GE crops raised (National 
Academies of Sciences, Engineering, and 
Medicine, 2016). The committee made 
every effort to address public concerns by 
answering all questions raised during the 
public meetings and through the website of 
the study1. The report acknowledged that 
GE was more than a technical issue, and 
that some of the questions raised did not 
have a simple right/wrong simple answer. 
Indeed, many of the report conclusions came 
with caveats. Additionally, the committee 
researched all funding sources for the 
scientific studies reviewed and made the 
information available through the online 
report. More importantly, the release 
of the report was followed by extensive 
communication with media outlets and 
public presentations, further discussions 
with various stakeholders and follow up 
publications (see Gould et al., 2017). In 
sum, the report did generate fruitful and 
constructive discussions about the topic, which should 
be the goal of any good communication exercise.
■■ MOVING	FORWARD
Communication about biotechnologies is complex 
since it needs to take into account the social, cultural, 
and political contexts in which the technologies are 
deployed and the many issues they raise. Debates 
related to biotechnologies have often more to do with 
the ethical, legal and social implications of the use 
of the technologies rather than with the science itself. 
Communication about biotechnologies has therefore 
to go beyond the communication of established 
scientific facts and has to start with an understanding 
of the public audiences and of their concerns. 
It is therefore crucial that all scientists involved 
acknowledge that the questions raised often do not 
have simple answers and that it is legitimate for the 
public to raise questions that go beyond the science. 
It is also important to recognize that individuals form 
attitudes toward new technologies through complex 
mechanisms and that simply explaining scientific 
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At the end of the day, societies need to make policy 
decisions related to new, complex technologies based 
on input by all relevant stakeholders, through public 
engagement mechanisms and dialogue.
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«DEBATES RELATED TO 
BIOTECHNOLOGIES HAVE OFTEN MORE 
TO DO WITH THE ETHICAL, LEGAL AND 
SOCIAL IMPLICATIONS, RATHER THAN 
WITH THE SCIENCE ITSELF»
